Demonstrating the Protective Efficacy of the Novel Fluoroquinolone Finafloxacin against an Inhalational Exposure to Burkholderia pseudomallei.

Barnes, Kay B; Hamblin, Karleigh A; Richards, Mark I; Laws, Thomas R; Vente, Andreas; Atkins, Helen S; Harding, Sarah V

Barnes, Kay B; Hamblin, Karleigh A; Richards, Mark I; Laws, Thomas R; Vente, Andreas; Atkins, Helen S; Harding, Sarah V.

Afiliação

Barnes KB; CBR Division, Defence Science and Technology Laboratory, Porton Down, Salisbury, United Kingdom kbbarnes@dstl.gov.uk.
Hamblin KA; CBR Division, Defence Science and Technology Laboratory, Porton Down, Salisbury, United Kingdom.
Richards MI; CBR Division, Defence Science and Technology Laboratory, Porton Down, Salisbury, United Kingdom.
Laws TR; CBR Division, Defence Science and Technology Laboratory, Porton Down, Salisbury, United Kingdom.
Vente A; MerLion Pharmaceuticals, Berlin, Germany.
Atkins HS; CBR Division, Defence Science and Technology Laboratory, Porton Down, Salisbury, United Kingdom.
Harding SV; University of Exeter, Exeter, United Kingdom.

Antimicrob Agents Chemother ; 61(7)2017 07.

Article em En | MEDLINE | ID: mdl-28438936

Assuntos

Antibacterianos/farmacologia; Burkholderia pseudomallei/efeitos dos fármacos; Fluoroquinolonas/farmacologia; Animais; Ciprofloxacina/farmacologia; Concentração de Íons de Hidrogênio; Camundongos; Testes de Sensibilidade Microbiana

Palavras-chave

Burkholderia; aerosol; finafloxacin; mouse model

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Burkholderia pseudomallei / Fluoroquinolonas / Antibacterianos Limite: Animals Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google